Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

City View Green: A Promising New ACMPR Applicant About to Go Public -- CFN Media

Posted on: 19 Jun 18

SEATTLE, WA , June 19, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article covering City View Green. The company plans to go public through a reverse merger with Icon Exploration Inc. (TSX-V: IEX), which was outlined in a non-binding letter of intent on January 22, 2018. After the share exchange takes place, the company will raise $2 million in interim financing to execute on its business plans, which will result in about 160 million shares outstanding. City View will own approximately 80 percent of the outstanding shares at the point with the balance being owned by existing Icon Exploration shareholders.

The Canadian cannabis industry is projected to exceed C$22.6 billion over the coming years as adult-use legalization goes into effect and export markets open up. With growing domestic and global demand, some analysts are projecting a shortfall in production that could benefit licensed producers. Many investors have anticipated this and sent valuations sharply higher, which has made the market for newly public companies increasingly appealing to investors.

Rapidly Growing Market

Canada’s cannabis industry is projected to exceed C$22.6 billion over the coming years, according to Deloitte, driven by the federal-level legalization of medical and adult-use cannabis. According to Health Canada, there are more than one hundred licensed producers in the market today, and more coming online each month. These licensed producers sold more than 6,000 kilograms of dried cannabis and more than 9,000 kilograms of cannabis oil in Q3’17.

Health Canada projects that cannabis demand will continue to soar to one million kilograms by the end of this year, while supply was just around 300,000 kilograms by early this year. With the legalization of adult-use cannabis just around the corner, these dynamics point toward a potential shortfall in production that could create tremendous opportunities for licensed producers that have been ramping up their production capacity.

City View Green’s Plans

City View Green is targeting entry into the cannabis market this year as a high-quality, large-scale producer located in Brantford, ON near Toronto. There the company plans to operate a 40,000 sq. ft. facility and utilize about 20,000 sq. ft. for cultivation activities, which management believes could produce about 5,000 kilograms per year of pharmaceutical-grade cannabis for both the medical and adult-use markets.

While many licensed producers are focused exclusively on scaling, the company is focused on efficiently growing the best products. Management plans on incorporating advancements in LED lighting, HVAC and dehumidification, and automation technologies to improve the quality, safety, output, and consistency of its cannabis production. These attributes could make it more profitable play than many competitors targeting the low end of the market.

In addition to its use of advanced technologies, the company believes that its strategic location should enable it to draw on the best talent available since it’s near colleges and universities. FDi, a division of the Financial Times, ranked Brantford as the top spot on its list of the most business-friendly cities in the micro city category in 2017/2018. These dynamics could further position it favorably within the burgeoning market.

Going Public Soon

Currently, investors cannot purchase shares in City View Green, as Icon Exploration trading has been halted until the transaction is completed. Canadian investors will be able to purchase shares immediately when trading resumes following the transaction, while U.S. investors may purchase shares through brokerage accounts that permit trading on the Toronto Venture Exchange (TSX-V), such as TDAmeritrade or InteractiveBrokers.

Please follow the link to read the full article:

About CFN Media

CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.

Learn how to become a CFN Media client company, brand or entrepreneur:

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand:

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone:

Disclaimer is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate., a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. received compensation for producing and presenting high quality and sophisticated content on along with financial and corporate news.  

The above article is sponsored content. Emerging Growth LLC, which owns and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation:

CONTACT: Contact: Frank Lane 206 369 7050 GlobeNewswire

Last updated on: 19/06/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.